Project

The project module is designed to value licensed or unlicensed drug development projects in a guided framework supported by proposed industry data. You get deep insight into the value, potential, and risk profile of each project. The module helps to:

• Test the financial viability of your project
• Calculate the internal rate of return (IRR)
• Find the minimum peak sales that justify starting the next phase
• Compare the financial potential of different projects
• Justify the budget for your project
• Analyze the value drivers to see their impact on the value
• Find the probability of reaching commercialization
• Assess the project risk profile
• Simulate different scenarios of project outcomes
• Forecast the future value increase of the project

• Project development phase
• Patent life
• Disease category
• Number of indications
• Development cost per indication and per phase (by user or proposed by ri:val)
• Development time per indication and per phase (by user or proposed by ri:val)
• Development success rate per indication and per phase (by user or proposed by ri:val)
• Review time (per geographic market, by user, or proposed by ri:val)
• Review cost (per geographic market, by user, or proposed by ri:val)
• Review success rate (per geographic market, by user, or proposed by ri:val)
• Sales potential
• Sales curve (per geographic market, by user, or proposed by ri:val)
• Cost of goods and marketing and sales expenses
• Risk profile
• License terms (if licensed)

Results

• Value (rNPV, real option value)
• Internal rate of return
• Value composition
• Value development
• Risk profile
• Monte Carlo simulations
• Development thresholds
• Development timelines
• Report